The Lallemand group, parent company of Lallemand Health Solutions, is a private Canadian company specializing in the development, production and marketing of yeasts, bacteria and other ingredients linked to these microorganisms or their market.

Lallemand Health Solutions: vertically integrated probiotic manufacturer

Lallemand Health Solutions is a vertically integrated probiotic manufacturer specialized in the research, development and manufacturing of ready-to-market and custom probiotic formulations. Its products target specific populations and health segments including Gut health, Natural defenses, Brain-Gut axis, Women’s health, Skin health, Oral health, Sport and Metabolism. Probiotics are produced in cutting-edge plants certified to the highest quality. More than 600 probiotic formulas are currently marketed in over 60 countries across five continents.

Full control is key

From lab to shelf, Lallemand Health Solutions has the full control and expertise to produce premium probiotic solutions, blends and custom formulations as each development step is expertly supported by internal quality insurance, regulatory affairs, research and development, scientific affairs, technical support, sales and marketing teams.

Scientific commitment

The Rosell® Institute for Microbiome and Probiotics by Lallemand, Lallemand Health Solutions’ research and development center located at the National Research Council of Canada in Montreal, develops partnerships with key scientific experts in order to study the human microbiome and how probiotic supplements can be used as a mean to improve or maintain health in specific populations or health segments. The research team has issued over 330 publications including 160 clinical studies.

1. Gut Health – Balanced gut flora. Embrace well-being.
Lallemand Health Solutions has an exclusive line of Expert’Biotics to support gut health and well-being. These solutions can be formulated into adapted dosage forms. B. LACTIS LAFTI® B94 which is now GRAS, has recently been recognized as safe to be used as an ingredient in powdered milk-based infant formula. In 2017, Lafti B94 obtained recognition of efficacy through strong specific health claims in Canada for various intestinal and gastrointestinal condition in infant and children populations. Within the Expert’Biotics line, Lacidofil is a unique combination scientifically backed by 26 clinical studies (13 in children and 13 in adults) for is demonstrated efficacy in gut-related fields.

https://lallemand-health-solutions.com/en/gastro/

2. Natural Defenses – Probiotics to help keep your family healthy 
Lallemand Health Solutions has a large portfolio of Expert’Biotics to support Natural Defenses, backed by specific Canadian health claims. Probiokid®, a combination of L. helveticus Rosell®-52, B. infantis Rosell®-33, B. bifidum Rosell®-71 and Fructo-oligosaccharides (FOS), is documented by eleven clinical studies in infants and children showing it helps to reinforce the body’s natural defenses in those specific populations. L. helveticus LAFTI® L10 has been tested in three clinical studies in active people. Being the first clinically tested probiotic strain for athletes’ immune health, it has been granted a Canadian health claim on the reduction of the incidence of cold-like symptoms in adults with exercise-induced stress. B. bifidum Rosell®-71 is backed by one large clinical study in 600 stressed students demonstrating support of immunity and healthy state in occasional stressful times (e.g. exam time).
https://lallemand-health-solutions.com/en/immunity/probiotics-for-the-whole-family/

3. Brain-Gut axis – CEREBIOME®: Pioneering psychobiotic. Game-changing science.
As pioneer and expert in research on the brain-gut axis, Lallemand Health Solutions has launched the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175. CEREBIOME® is scientifically backed by five clinical studies showing significant decrease of both gut disturbances induced by psychological stress in healthy people and psychological stress and eight demonstrated modes of action on the brain-gut axis. These evidences have brought exclusive and strong health claims on mood and stress by Canadian and Brazilian health authorities. Lallemand Health Solutions developed a new informative hub, regrouping a mine of facts and evidences on the power of psychobiotics, paving the way to innovative science.
https://cerebiomebylallemand.com/

4. Women’s health – ROSELLA: An ally for a healthy intimate flora.

A convenient orally administered probiotic shown to support women’s intimate health. L. plantarum ROSELLA is a unique strain isolated from a healthy vaginal flora with full mechanistic and clinical evidence of efficacy on a wide spectrum of benefits from helping to maintain proper vaginal balance, including oral intake, to being used for recurrent Vulvovaginal Candidiasis (rVVC). Studied on over 800 women in six clinical studies including two with oral treatment ROSELLA has shown to help promote vaginal health in recurrent VVC alone or as adjunctive treatment (anti-fungal) and demonstrated vaginal colonization and persistence following oral intake (validated efficacy dose: 5B/day).

https://lallemand-health-solutions.com/en/women-health/

5. Did you meet the latest addition to our family?

Lallemand Health Solutions has a large portfolio of EXPERT’Biotics solutions, including Lacidofil®, Probiokid®, Lafti B94®, S. boulardii, L. rhamnosus GG, and L. reuteri Rosell®-444 strains, with clinical evidences to prove their safety and efficacy, especially for babies and children. There are two new safety studies in healthy infants, aged less than one-year old, additionally to over 30 studies performed in infants and young children, showing these particular probiotic supplements support gut health and natural defenses and provide health benefits such as baby-specific microflora balance, maintenance of standard IgA levels and increased stool frequency in formula-fed babies. Four strains have the GRAS status and three of Lallemand Health Solutions probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed the approval process by the National Health Commission of the People’s Republic of China for use in infant food.

https://lallemand-health-solutions.com/en/babies/

For more information, please contact us!

https://lallemand-health-solutions.com/

Healthsolutions@lallemand.com

Follow us on Linked’in

Lallemand Health Solutions